| 货号 | 规格 | 价格 | 上海 | 北京 | 武汉 | 南京 | 购买数量 |
|---|---|---|---|---|---|---|---|
| S88517-1mg | ≥98% | ￥348.00 | 10 | - | - | - |
|
| S88517-5mg | ≥98% | ￥1046.00 | 10 | - | - | - |
|
| S88517-10mg | ≥98% | ￥1464.00 | 9 | - | - | - |
|
| S88517-25mg | ≥98% | ￥2929.00 | 6 | - | - | - |
|
| S88517-50mg | ≥98% | ￥4687.00 | 4 | - | - | - |
|
| S88517-100mg | ≥98% | ￥7499.00 | 1 | - | - | - |
|
SRI 31215 (TFA) is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 μM, 0.65 μM and 0.30 μM, respectively. SRI 31215 can be used for the research of cancer[1]
| 外观： | Light yellow to khaki (Solid) |
|---|---|
| 溶解性： | Soluble in DMSO |
| 储存条件： | -20°C |
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京